Sun, Y., Li, F., Sonnemann, H., Jackson, K. R., Talukder, A. H., Katailiha, A. S., & Lizee, G. (2021, September). Evolution of CD8<sup>+</sup> T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. Cells.
Chicago Style (17th ed.) CitationSun, Yimo, Fenge Li, Heather Sonnemann, Kyle R. Jackson, Amjad H. Talukder, Arjun S. Katailiha, and Gregory Lizee. "Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer." Cells Sep. 2021.
MLA (9th ed.) CitationSun, Yimo, et al. "Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer." Cells, Sep. 2021.
Warning: These citations may not always be 100% accurate.
